HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Robert T Jensen Selected Research

Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison)

2/2013Pharmacotherapy of Zollinger-Ellison syndrome.
11/2007Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.
11/2006Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
11/2006Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
1/2006Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
5/2005Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
12/2004Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.
2/2002Cytokine gene profile in gastric mucosa in Helicobacter pylori infection and Zollinger-Ellison syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Robert T Jensen Research Topics

Disease

42Neoplasms (Cancer)
02/2016 - 01/2002
16Lung Neoplasms (Lung Cancer)
10/2015 - 05/2002
14Gastrinoma
11/2007 - 01/2002
11Multiple Endocrine Neoplasia Type 1 (MEN I)
11/2013 - 03/2003
8Neoplasm Metastasis (Metastasis)
05/2013 - 07/2002
8Carcinoid Tumor (Carcinoid)
03/2013 - 12/2002
8Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison)
02/2013 - 02/2002
7Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2014 - 01/2003
7Pancreatitis
07/2014 - 01/2005
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2014 - 01/2003
3Breast Neoplasms (Breast Cancer)
02/2016 - 07/2006
3Primitive Neuroectodermal Tumors (PNET)
11/2014 - 07/2012
3Chronic Pancreatitis
07/2014 - 12/2002
3Hyperparathyroidism
02/2013 - 12/2003
2Obesity
01/2015 - 03/2013
2Body Weight (Weight, Body)
01/2015 - 05/2010
2Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
08/2013 - 12/2008
2Inflammation
01/2013 - 02/2002
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
12/2007 - 12/2002
2Hyperplasia
11/2006 - 12/2002
2Infection
11/2006 - 02/2002
2Peptic Ulcer (Peptic Ulcers)
02/2006 - 01/2006
2Gastritis
01/2006 - 07/2002
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2005 - 01/2003
2Colonic Neoplasms (Colon Cancer)
05/2004 - 12/2002
1Neuroblastoma
02/2016
1Hyperphagia
01/2015
1Hypertension (High Blood Pressure)
01/2015
1Diabetes Mellitus
01/2014
1Primary Hyperparathyroidism
08/2013

Drug/Important Bio-Agent (IBA)

12GastrinsIBA
07/2015 - 01/2002
10Tyrosine (L-Tyrosine)FDA Link
07/2015 - 05/2002
8BombesinIBA
10/2015 - 06/2002
8Bombesin Receptors (Bombesin Receptor)IBA
02/2015 - 08/2003
7HormonesIBA
05/2013 - 08/2003
6Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
02/2016 - 01/2003
6PeptidesIBA
10/2015 - 06/2002
6Epidermal Growth Factor Receptor (EGF Receptor)IBA
07/2015 - 07/2010
6bombesin receptor subtype 3IBA
02/2015 - 02/2008
6Messenger RNA (mRNA)IBA
11/2007 - 02/2002
5Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
02/2016 - 11/2002
5Glucose (Dextrose)FDA LinkGeneric
01/2015 - 02/2008
5Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2012 - 01/2002
5DNA (Deoxyribonucleic Acid)IBA
01/2012 - 08/2002
5Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
09/2007 - 01/2003
4Epidermal Growth Factor (EGF)IBA
02/2016 - 07/2002
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2015 - 01/2003
4Cholecystokinin (Pancreozymin)IBA
07/2015 - 12/2002
4SecretinFDA Link
11/2007 - 08/2003
3NeurotensinIBA
10/2015 - 05/2002
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2015 - 08/2011
3Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
07/2015 - 12/2002
3Chromogranin AIBA
11/2014 - 07/2003
3CytokinesIBA
07/2014 - 02/2002
3ChemokinesIBA
07/2014 - 01/2013
3Somatostatin Receptors (Somatostatin Receptor)IBA
12/2012 - 03/2003
3Phosphatidylinositols (Phosphatidylinositol)IBA
11/2012 - 01/2012
3Proton Pumps (Proton Pump)IBA
12/2010 - 07/2002
3CalciumIBA
12/2010 - 11/2006
3neuromedin BIBA
07/2010 - 06/2002
3Proton Pump InhibitorsIBA
12/2009 - 01/2006
3Gastrin-Releasing PeptideIBA
02/2008 - 06/2002
3CamptothecinIBA
09/2007 - 05/2004
2CytotoxinsIBA
02/2016 - 09/2006
2NeuropeptidesIBA
10/2015 - 01/2003
2Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
07/2015 - 03/2013
2gefitinib (Iressa)FDA Link
07/2015 - 06/2012
2Insulin (Novolin)FDA Link
01/2015 - 08/2010
2LigandsIBA
10/2013 - 08/2011
2Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
11/2012 - 06/2012
2Focal Adhesion Protein-Tyrosine KinasesIBA
01/2012 - 05/2002
2NF-kappa B (NF-kB)IBA
01/2012 - 08/2011
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
12/2010 - 01/2006
2IronIBA
12/2010 - 01/2006
2Octreotide (Sandostatin)FDA LinkGeneric
08/2010 - 01/2002
2Biological Markers (Surrogate Marker)IBA
03/2010 - 12/2004
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
05/2008 - 12/2004
2Transforming Growth Factor beta (TGF-beta)IBA
01/2006 - 08/2002
2PD 176252IBA
01/2006 - 08/2003
2Type I Vasoactive Intestinal Polypeptide ReceptorsIBA
01/2005 - 01/2004
2(VIP-neurotensin) hybrid antagonistIBA
01/2004 - 01/2003
1Superoxides (Superoxide)IBA
07/2015
11,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA
07/2015
1GM 6001IBA
07/2015
1PD 134308IBA
07/2015
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
07/2015
1gastrin 17 (G 17)IBA
07/2015
1SincalideFDA Link
07/2015
1Neurotransmitter Agents (Neurotransmitter)IBA
07/2015
1Chemokine CX3CL1IBA
07/2014
1CollagenIBA
01/2014
1glucagon-like peptide receptor (receptor, glucagon-like peptide)IBA
01/2014
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2014
1Parathyroid Hormone (Parathormone)IBA
08/2013

Therapy/Procedure

5Parathyroidectomy
08/2013 - 12/2003
3Heterologous Transplantation (Xenotransplantation)
08/2011 - 09/2006
3Pancreaticoduodenectomy
02/2006 - 08/2003
2Drug Therapy (Chemotherapy)
02/2013 - 01/2002
2Thymectomy
06/2012 - 12/2008
2Gastrectomy
12/2004 - 11/2004